DIANEAL PD-2 with Dextrose

Manufacturer
Vantive US Healthcare LLC | Baxter, S.A. de C.V. | VANTIVE MANUFACTURING LIMITED
Effective date
2026-04-16
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
38
Source
daily-update
Hydrated at
2026-11-14 03:03:53

Label at a glance#

ProductDIANEAL PD-2 with Dextrose
Active ingredientDEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE
Label structure15 sections

Indications and uses

DIANEAL peritoneal dialysis solutions are indicated for patients in acute or chronic renal failure.

Dosage and administration

DIANEAL peritoneal dialysis solutions are intended for intraperitoneal administration only. Not for intravenous or intra-arterial administration. Select mode of therapy, frequency of treatment, formulation, fill volume, duration of dwell, and length of dialysis based on the patient’s clinical condition, fluid, electrolyte and specific needs. The fill volume depends on body size, usually from 2.0 to 2.5 liters per ...

Storage and handling

DIANEAL peritoneal dialysis solutions are available in the following single-dose containers and fill volumes as shown in Tables 6-7. The solution is clear with color being slightly yellow to colorless. Table 6 - DIANEAL Peritoneal Dialysis Solutions for CAPD therapy Container Fill Volume (mL) Container Size (mL) Product Code NDC ULTRABAG Container DIANEAL PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose 2000 2...

Label contents#

Full prescribing information#

1 INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

DIANEAL peritoneal dialysis solutions are indicated for patients in acute or chronic renal failure.

2 DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

2.1 Basic Dosing Information

SPL UNCLASSIFIED SECTION

DIANEAL peritoneal dialysis solutions are intended for intraperitoneal administration only. Not for intravenous or intra-arterial administration.

Select mode of therapy, frequency of treatment, formulation, fill volume, duration of dwell, and length of dialysis based on the patient’s clinical condition, fluid, electrolyte and specific needs. The fill volume depends on body size, usually from 2.0 to 2.5 liters per 1.73m2 for adults.

DIANEAL peritoneal dialysis solutions are intended for use in Continuous Ambulatory Peritoneal Dialysis (CAPD) or Automated Peritoneal Dialysis (APD). Refer to directions accompanying ancillary equipment for CAPD and APD system preparation.

Product Selection

To avoid the risk of severe dehydration and hypovolemia and to minimize the loss of protein, it is advisable to select the peritoneal dialysis solution with the lowest level of osmolarity consistent with the fluid removal requirements for that exchange. As the patient’s body weight becomes closer to the ideal dry weight, lowering the dextrose concentration of DIANEAL solution is recommended. DIANEAL 4.25% dextrose-containing solution has the highest osmolarity of the DIANEAL solutions and using it for all exchanges may cause dehydration [see Dosage Forms and Strengths (3)].

2.2 Adding Medications

SPL UNCLASSIFIED SECTION

If the resealable rubber plug on the medication port is missing or partly removed, do not use the product if medication is to be added.

To add a medication:

  1. Put on mask. Clean and/or disinfect hands.
  2. Prepare medication port site using aseptic technique.
  3. Using a syringe with a 1-inch long, 25- to 19-gauge needle, puncture the medication port and inject additive.
  4. Reposition container with container ports up and evacuate medication port by squeezing and tapping it.
  5. Mix solution and additive thoroughly.

2.3 Directions for Use

SPL UNCLASSIFIED SECTION

Warming

DIANEAL peritoneal dialysis solution can be warmed to 37°C (98.6°F). Only dry heat should be used. For CAPD, it is best to warm solutions within the overwrap using a heating pad. Do not immerse DIANEAL solutions in water for warming. Do not use a microwave oven to warm DIANEAL solutions.

To Open

To open, tear the overwrap down at the slit and remove the solution container. Do not use sharp objects to remove the overwrap.

Product Inspection

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Do not use solutions that are cloudy, discolored, contain visible particulate matter, or show evidence of leakage. Some opacity of the plastic, due to moisture absorption during the sterilization process, may be observed. This does not affect the solution quality or safety and may often leave a slight amount of moisture within the overwrap. The opacity should diminish gradually.

Inspect the bag connector to ensure the tip protector (pull ring or blue pull tip) is attached. Do not use if the tip protector is not attached to the connector. Inspect the DIANEAL solution container for signs of leakage and check for minute leaks by squeezing the container firmly. If the container has frangible(s), inspect that they are positioned correctly and are not broken. Do not use DIANEAL solution if the frangible(s) are broken or leaks are suspected as sterility may be impaired.

For DIANEAL solutions in ULTRABAG containers, inspect the tubing and drain container for presence of solution. Small droplets are acceptable, but if solution flows past the frangible prior to use, do not use and discard the units.

CAPD therapy using ULTRABAG containers

Select appropriate formulation from Table 1.

Put on mask. Clean and/or disinfect hands. Using aseptic technique;

  1. Uncoil tubing and drain bag, ensuring that the transfer set is closed.
  2. Break the connector (Y-set) frangible.
  3. Remove the tip protector from connector of solution container. Do not reuse the solution or container once the tip protector is removed.
  4. Immediately attach the solution container to patient connector (transfer set).
  5. Clamp solution line and then break frangible near solution bag. Hang solution container and place the drainage container below the level of the abdomen.
  6. Open transfer set to drain the solution from abdomen. If drainage cannot be established, contact your clinician. When drainage complete, close transfer set.
  7. Remove clamp from solution line and flush new solution to flow into the drainage container for 5 seconds to prime the line. Clamp drain line after flush complete.
  8. Open transfer set to fill. When fill complete, close transfer set.
  9. Disconnect ULTRABAG container from transfer set and apply MINICAP disconnect cap.
  10. Upon completion of therapy, discard any unused portion.

APD therapy using AMBU-FLEX containers with pull rings or plastic containers with blue pull tips or pull rings

Select appropriate formulation from Table 1, 2 or 3.

Put on mask. Clean and/or disinfect hands. Using aseptic technique;

  1. Remove the tip protector from connector of solution container. Do not reuse the solution or container once the tip protector is removed.
  2. Immediately attach the solution container to an appropriate automated peritoneal dialysis set.
  3. Continue therapy as instructed in user manual or directions accompanying tubing sets for automated peritoneal dialysis.
  4. Upon completion of therapy, discard any unused portion.

3 DOSAGE FORMS AND STRENGTHS

DOSAGE FORMS & STRENGTHS SECTION

DIANEAL peritoneal dialysis solution is clear with color being slightly yellow to colorless and is formulated with the following ionic concentrations:

Table 1 - DIANEAL PD-2 and Low Calcium Peritoneal Dialysis Solution ULTRABAG Container for CAPD therapy AMBU-FLEX Container with pull ring for APD therapy
Ionic Concentration
(mEq/L)
OSMOLARITY
(mOsmol/L) (calc)
pHSodiumCalciumMagnesiumChlorideLactate

DIANEAL PD-2
1.5% Dextrose

346

5.2
(4.0 to 6.5)

132

3.5

0.5

96

40

DIANEAL PD-2
2.5% Dextrose

396

5.2
(4.0 to 6.5)

132

3.5

0.5

96

40

DIANEAL PD-2
4.25% Dextrose

485

5.2
(4.0 to 6.5)

132

3.5

0.5

96

40

DIANEAL Low Calcium
(2.5 mEq/L)
1.5% Dextrose

344

5.2
(4.0 to 6.5)

132

2.5

0.5

95

40

DIANEAL Low Calcium
(2.5 mEq/L)
2.5% Dextrose

395

5.2
(4.0 to 6.5)

132

2.5

0.5

95

40

DIANEAL Low Calcium
(2.5 mEq/L)
4.25% Dextrose

483

5.2
(4.0 to 6.5)

132

2.5

0.5

95

40

Table 2 - DIANEAL Low Calcium Peritoneal Dialysis Solution Plastic container with blue pull tip for APD therapy
Ionic Concentration
(mEq/L)
OSMOLARITY
(mOsmol/L) (calc)
pHSodiumCalciumMagnesiumChlorideLactate

DIANEAL Low Calcium
(2.5 mEq/L)
1.5% Dextrose

344

5.0 to 6.5

132

2.5

0.5

95

40

DIANEAL Low Calcium
(2.5 mEq/L)
2.5% Dextrose

395

5.0 to 6.5

132

2.5

0.5

95

40

DIANEAL Low Calcium
(2.5 mEq/L)
4.25% Dextrose

483

5.0 to 6.5

132

2.5

0.5

95

40

Table 3 – DIANEAL PD-2 and DIANEAL Low Calcium Peritoneal Dialysis Solution Plastic container with pull ring for APD therapy
OSMOLARITY
(mOsmol/L) (calc)
pHIonic Concentration
(mEq/L)
SodiumCalciumMagnesiumChlorideLactate

DIANEAL PD-2

1.5% Dextrose

346

5.0 to 5.6

132

3.5

0.5

96

40

DIANEAL PD-2

2.5% Dextrose

396

5.0 to 5.6

132

3.5

0.5

96

40

DIANEAL PD-2

4.25% Dextrose

485

5.0 to 5.6

132

3.5

0.5

96

40

DIANEAL Low Calcium (2.5 mEq/L) 1.5% Dextrose

344

5.0 to 5.6

132

2.5

0.5

95

40

DIANEAL Low Calcium (2.5 mEq/L) 2.5% Dextrose

395

5.0 to 5.6

132

2.5

0.5

95

40

DIANEAL Low Calcium (2.5 mEq/L) 4.25% Dextrose

483

5.0 to 5.6

132

2.5

0.5

95

40

4 CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

DIANEAL peritoneal dialysis solutions are contraindicated in patients with severe lactic acidosis.

5 WARNINGS AND PRECAUTIONS

WARNINGS AND PRECAUTIONS SECTION

5.1 Peritonitis and Encapsulating Peritoneal Sclerosis

SPL UNCLASSIFIED SECTION

Peritonitis has been associated with DIANEAL peritoneal dialysis solution use. Following use, inspect the drained fluid for the presence of fibrin or cloudiness, which may indicate the presence of peritonitis. Improper clamping or priming sequence may result in infusion of air into the peritoneal cavity, which may result in abdominal pain and/or peritonitis. If peritonitis occurs, treat with appropriate therapy.

Encapsulating Peritoneal Sclerosis (EPS), sometimes fatal, is a complication of peritoneal dialysis therapy and has been reported in patients using DIANEAL solutions.

5.2 Lactic Acidosis

SPL UNCLASSIFIED SECTION

Monitor patients with conditions known to increase the risk of lactic acidosis [e.g., severe hypotension or sepsis that can be associated with acute renal failure, hepatic failure, inborn errors of metabolism, and treatment with drugs such as nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)] before the start of treatment and during treatment with lactate-based peritoneal dialysis solutions. Use of DIANEAL solutions in patients with severe lactic acidosis is contraindicated [see Contraindications (4)].

5.3 Overinfusion

SPL UNCLASSIFIED SECTION

Overinfusion of peritoneal dialysis solution volume into the peritoneal cavity may be characterized by abdominal distention, feeling of fullness and/or shortness of breath. Drain the peritoneal dialysis solution from the peritoneal cavity to treat overinfusion.

5.4 Electrolyte, Fluid, and Nutrition Imbalances

SPL UNCLASSIFIED SECTION

Peritoneal dialysis may affect a patient’s protein, water-soluble vitamin, potassium, bicarbonate, calcium, and magnesium levels and volume status. Monitor hematology, electrolytes, blood chemistry and fluid status periodically and take appropriate clinical action.

Potassium is omitted from DIANEAL solutions because dialysis may be performed to correct hyperkalemia. In situations where there is a normal serum potassium level or hypokalemia, addition of potassium chloride (up to a concentration of 4 mEq/L) to the solution may be necessary to prevent severe hypokalemia. Monitor fluid status to avoid hyper- or hypovolemia and potentially severe consequences including congestive heart failure, volume depletion and hypovolemic shock.

5.5 Hyperglycemia

SPL UNCLASSIFIED SECTION

DIANEAL solutions contain dextrose and may increase the risk for hyperglycemia in patients with impaired glucose tolerance. Patients may require initiation or modification of antidiabetic therapy during treatment with DIANEAL solutions. Monitor blood glucose.

6 ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

The following adverse reactions are discussed elsewhere in the label:

Peritonitis and Encapsulating Peritoneal Sclerosis [see Warnings and Precautions (5.1)]
Electrolyte and Fluid Imbalances [see Warnings and Precautions (5.4)]

6.1 Clinical Trials Experience

SPL UNCLASSIFIED SECTION

There are no data available on adverse reactions from controlled clinical trials conducted to evaluate the safety of DIANEAL peritoneal dialysis solutions.

6.2 Post-Marketing Experience

SPL UNCLASSIFIED SECTION

The following adverse experiences have been identified during post-approval use of DIANEAL solutions or in conjunction with performing the peritoneal dialysis procedure. Because these experiences are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship during drug exposure. Most of these adverse experiences are believed to be consequences of peritoneal dialysis.

INFECTIONS AND INFESTATIONS: Fungal peritonitis, Peritonitis bacterial, Catheter related infection

METABOLISM AND NUTRITION DISORDERS: Hypovolemia, Hypervolemia, Fluid retention, Hypokalemia, Hyponatremia, Dehydration, Hypochloremia

VASCULAR DISORDERS: Hypotension, Hypertension

RESPIRATORY, THORACIC, AND MEDIASTINAL DISORDERS: Dyspnea

GASTROINTESTINAL DISORDERS: Sclerosing encapsulating peritonitis, Peritonitis, Peritoneal cloudy effluent, Vomiting, Diarrhea, Nausea, Constipation, Abdominal pain, Abdominal distension, Abdominal discomfort

SKIN AND SUBCUTANEOUS DISORDERS: Stevens-Johnson syndrome, Urticaria, Rash, (including pruritic, erythematous and generalized), Pruritus

MUSCULOSKELETAL, CONNECTIVE TISSUE DISORDERS: Myalgia, Muscle spasms, Musculoskeletal pain

GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS: Generalized edema, Pyrexia, Malaise, Infusion site pain, Catheter related complication

7 DRUG INTERACTIONS

DRUG INTERACTIONS SECTION

As with other dialysis solutions, blood concentrations of dialyzable drugs may be reduced by dialysis. Dosage adjustment of concomitant medications may be necessary.

Diabetic patients may require dosage adjustments of insulin or other treatments for hyperglycemia [see Warnings and Precautions (5.5)].

8 USE IN SPECIFIC POPULATIONS

USE IN SPECIFIC POPULATIONS SECTION

8.1 Pregnancy

PREGNANCY SECTION

DIANEAL peritoneal dialysis solution is a pharmacologically inactive solution. While there are no adequate and well controlled studies in pregnant women, appropriate administration of DIANEAL solutions, with appropriate monitoring of hematology, electrolytes, blood chemistry and fluid status is not expected to cause fetal harm. Animal reproduction studies have not been conducted with DIANEAL solutions.

The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively.

8.2 Lactation

SPL UNCLASSIFIED SECTION

The components of DIANEAL solutions are excreted in human milk.

8.4 Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness have been established based on published clinical data. No adequate and well-controlled studies have been conducted with DIANEAL solutions in pediatric patients.

8.5 Geriatric Use

GERIATRIC USE SECTION

Safety and effectiveness have been established based on published clinical data.

10 OVERDOSAGE

OVERDOSAGE SECTION

There is a potential for overdose resulting in hypervolemia, hypovolemia, electrolyte disturbances or hyperglycemia. Excessive use of DIANEAL peritoneal dialysis solution with 4.25% dextrose during a peritoneal dialysis treatment can result in significant removal of water from the patient.

11 DESCRIPTION

DESCRIPTION SECTION

DIANEAL peritoneal dialysis solutions are sterile, nonpyrogenic solutions in flexible containers for intraperitoneal administration only. The peritoneal dialysis solutions contain no bacteriostatic or antimicrobial agents. DIANEAL solutions are hyperosmolar solutions.

Table 4 - DIANEAL PD-2 and Low Calcium Peritoneal Dialysis Solution ULTRABAG Container for CAPD therapy AMBU-FLEX/Plastic Container with pull ring for APD therapy
Composition/100 mL
*Dextrose, Hydrous, USPSodium Chloride, USP (NaCl)Sodium Lactate (C3H5NaO3)Calcium Chloride, USP (CaCl2•2H2O)Magnesium Chloride, USP (MgCl2•6H2O)

DIANEAL PD-2
1.5% Dextrose

1.5 g

538 mg

448 mg

25.7 mg

5.08 mg

DIANEAL PD-2
2.5% Dextrose

2.5 g

538 mg

448 mg

25.7 mg

5.08 mg

DIANEAL PD-2
4.25% Dextrose

4.25 g

538 mg

448 mg

25.7 mg

5.08 mg

DIANEAL Low Calcium
(2.5 mEq/L)
1.5% Dextrose

1.5 g

538 mg

448 mg

18.3 mg

5.08 mg

DIANEAL Low Calcium
(2.5 mEq/L)
2.5% Dextrose

2.5 g

538 mg

448 mg

18.3 mg

5.08 mg

DIANEAL Low Calcium
(2.5 mEq/L)
4.25% Dextrose

4.25 g

538 mg

448 mg

18.3 mg

5.08 mg

Table 5 - DIANEAL Low Calcium Peritoneal Dialysis Solution Plastic container with blue pull tip for APD therapy
Composition/100 mL
*Dextrose, HydrousSodium Chloride (NaCl)Sodium Lactate (C3H5NaO3)Calcium Chloride (CaCl2•2H2O)Magnesium Chloride (MgCl2•6H2O)

DIANEAL Low Calcium
(2.5 mEq/L)
1.5% Dextrose

1.5 g

538 mg

448 mg

18.4 mg

5.08 mg

DIANEAL Low Calcium
(2.5 mEq/L)
2.5% Dextrose

2.5 g

538 mg

448 mg

18.4 mg

5.08 mg

DIANEAL Low Calcium
(2.5 mEq/L)
4.25% Dextrose

4.25 g

538 mg

448 mg

18.4 mg

5.08 mg

Structural Formula Dextrose Hydrous USP
Structural Formula Dextrose Hydrous USP

The plastic container is fabricated from polyvinyl chloride (PVC Plastic). Exposure to temperatures above 25°C/77°F during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period. The amount of water that can permeate from inside the solution container into the overwrap is insufficient to affect the solution significantly.

Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g. di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million; however, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by cell culture toxicity studies.

12 CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

12.1 Mechanism of Action

MECHANISM OF ACTION SECTION

DIANEAL peritoneal dialysis solutions are a pharmacologically inactive, hypertonic peritoneal dialysis solution containing dextrose, a monosaccharide, as the primary osmotic agent. An osmotic gradient must be created between the peritoneal membrane and the dialysis solution in order for ultrafiltration to occur. The hypertonic concentration of glucose in DIANEAL solutions exert an osmotic pressure across the peritoneal membrane resulting in transcapillary ultrafiltration. Like other peritoneal dialysis solutions, DIANEAL solutions contain electrolytes to facilitate the correction of electrolyte abnormalities. DIANEAL solutions contain a buffer, lactate, to help normalize acid-base abnormalities.

12.3 Pharmacokinetics

PHARMACOKINETICS SECTION

Absorption

Glucose is rapidly absorbed from the peritoneal cavity by diffusion and appears quickly in the circulation due to the high glucose concentration gradient between DIANEAL solutions compared to blood capillary glucose level. Absorption per unit time will be the highest at the start of an exchange and decreases over time. The rate of glucose absorption will be dependent upon the transport characteristics of the patient’s peritoneal membrane as determined by a peritoneal equilibration test (PET). Glucose absorption will also depend upon the concentration of glucose used for the exchange and the length of the dwell. Transport of other molecules will be dependent upon the molecular size of the solute, the concentration gradient, and the effective peritoneal surface area as determined by the PET.

Metabolism and Elimination

Glucose is metabolized by normal cellular pathways (i.e., glycolysis). Metabolism of lactate occurs in the liver and results in the generation of the bicarbonate. Glucose not absorbed during PD exchange procedure is removed by drainage of the PD solution from the peritoneal cavity.

Drug Interaction Studies

Heparin

No human drug interaction studies with heparin were conducted. In vitro studies demonstrated no evidence of incompatibility of heparin with DIANEAL solutions.

Antibiotics

No formal clinical drug interaction studies have been performed. In vitro studies of the following medications have demonstrated stability with DIANEAL solutions: amphotericin B, ampicillin, cefazolin, cefepime, cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, clindamycin, deferoxamine, erythromycin, gentamicin, linezolid, mezlocillin, miconazole, moxifloxacin, nafcillin, ofloxacin, penicillin G, piperacillin, sulfamethoxazole/trimethoprim, ticarcillin, tobramycin, and vancomycin. However, aminoglycosides should not be mixed with penicillins due to chemical incompatibility.

16 HOW SUPPLIED/STORAGE AND HANDLING

HOW SUPPLIED SECTION

DIANEAL peritoneal dialysis solutions are available in the following single-dose containers and fill volumes as shown in Tables 6-7. The solution is clear with color being slightly yellow to colorless.

Table 6 - DIANEAL Peritoneal Dialysis Solutions for CAPD therapy

Container

Fill Volume (mL)

Container Size (mL)

Product Code

NDC

ULTRABAG
Container

DIANEAL PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose

2000

2500

2000

3000

5B9866

5B9868

0941-0426-52

0941-0426-53

DIANEAL PD-2 Peritoneal Dialysis Solution with 2.5% Dextrose

2000

2500

2000

3000

5B9876

5B9878

0941-0427-52

0941-0427-53

DIANEAL PD-2 Peritoneal Dialysis Solution with 4.25% Dextrose

2000

2500

2000

3000

5B9896

5B9898

0941-0429-52

0941-0429-53

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 1.5% Dextrose

1500

2000

2500

2000

2000

3000

5B9765

5B9766

5B9768

0941-0424-51

0941-0424-52

0941-0424-53

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose

1500

2000

2500

2000

2000

3000

5B9775

5B9776

5B9778

0941-0430-51

0941-0430-52

0941-0430-53

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 4.25% Dextrose

1500

2000

2500

2000

2000

3000

5B9795

5B9796

5B9798

0941-0433-51

0941-0433-52

0941-0433-53

Table 7 - DIANEAL Peritoneal Dialysis Solutions for APD therapy

Container

Fill Volume (mL)

Container Size (mL)

Product Code

NDC

AMBU-FLEX / Plastic Container with pull ring

DIANEAL PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose

1000

2000

3000

5000

6000

1000

3000

3000

6000

6000

L5B5163

L5B5166

L5B5169

L5B5193

L5B9710

0941-0411-05

0941-0411-06

0941-0411-04

0941-0411-07

0941-0411-11

DIANEAL PD-2 Peritoneal Dialysis Solution with 2.5% Dextrose

1000

2000

3000

5000

6000

1000

3000

3000

6000

6000

L5B5173

L5B5177

L5B5179

L5B5194

L5B9711

0941-0413-05

0941-0413-06

0941-0413-04

0941-0413-07

0941-0413-01

DIANEAL PD-2 Peritoneal Dialysis Solution with 4.25% Dextrose

1000

2000

3000

5000

6000

1000

3000

3000

6000

6000

L5B5183

L5B5187

L5B5189

L5B5195

L5B9712

0941-0415-05

0941-0415-06

0941-0415-04

0941-0415-07

0941-0415-01

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 1.5%Dextrose

2000

3000

5000

6000

3000

3000

6000

6000

L5B4825

L5B9901

L5B4826

L5B9770

0941-0409-06

0941-0409-05

0941-0409-07

0941-0409-01

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose

2000

3000

5000

6000

3000

3000

6000

6000

L5B9727

L5B9902

L5B5202

L5B9771

0941-0457-08

0941-0457-02

0941-0457-05

0941-0457-01

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 4.25% Dextrose

2000

3000

5000

6000

3000

3000

6000

6000

L5B9747

L5B9903

L5B5203

L5B9772

0941-0459-08

0941-0459-02

0941-0459-05

0941-0459-01

Plastic container with blue pull tip

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 1.5% Dextrose

5000

5000

EZPB5245R

0941-0484-01

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose

5000

5000

EZPB5255R

0941-0487-01

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 4.25% Dextrose

5000

5000

EZPB5265R

0941-0490-01

All DIANEAL peritoneal dialysis solutions have overfills which are declared on container labeling.

Freezing of solution may occur at temperatures below 0°C (32°F). Allow to thaw naturally in ambient conditions and thoroughly mix contents by shaking.

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25°C/77°F): brief exposure up to 40°C (104°F) does not adversely affect the product.

Store in moisture barrier overwrap and in carton until ready to use.

17 PATIENT COUNSELING INFORMATION

INFORMATION FOR PATIENTS SECTION

Inspection: Advise patients to inspect DIANEAL peritoneal dialysis solutions before use, and not to use if the solution is cloudy, discolored, contains particulate matter or if there is evidence of leakage.

Administration: Advise patients on proper administration and the importance of using aseptic technique throughout the entire PD procedure. Advise patients only to use dry heat to warm solution to about 37°C (98°F) and not to microwave or submerge in water.

Peritonitis: Advise patients to seek medical attention if they experience signs or symptoms of peritonitis.

SPL UNCLASSIFIED SECTION

Vantive, Ambu-Flex, Dianeal, MiniCap and UltraBag are trademarks of Vantive Health LLC or its affiliates.

Vantive US Healthcare LLC
Deerfield, IL 60015 USA
Printed in USA

0719000005

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0941-0411-11 (07-25-00-0740) Container Label
NDC 0941-0411-11 (07-25-00-0740) Container Label

L5B9710 6000 mL
NDC 0941-0411-11(APPROX 225 mL EXCESS)

Vantive Logo

Dianeal PD-2
Peritoneal Dialysis Solution
with 1.5% Dextrose

EACH 100 mL CONTAINS 1.5 g DEXTROSE
HYDROUS USP 538 mg SODIUM CHLORIDE
USP 448 mg SODIUM LACTATE
25.7 mg CALCIUM CHLORIDE USP 5.08 mg
MAGNESIUM CHLORIDE USP pH 5.2 (4.0 TO
6.5)

mEq/L SODIUM - 132 CALCIUM - 3.5
MAGNESIUM - 0.5 CHLORIDE - 96
LACTATE - 40 OSMOLARITY - 346 mOsmol/L
(CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY
UNDER THE DIRECTION OF A PHYSICIAN

SEE PACKAGE INSERT FOR DOSAGE INFORMATION

USE AS DIRECTED BY PHYSICIAN

FOR INTRAPERITONEAL ADMINISTRATION ONLY

CAUTIONS SQUEEZE AND INSPECT INNER BAG
WHICH MAINTAINS PRODUCT STERILITY DISCARD IF
LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT
ROOM TEMPERATURE (25°C/77°F) UNTIL READY
TO USE
AVOID EXCESSIVE HEAT SEE INSERT

Ambu-Flex II CONTAINER

VANTIVE US HEALTHCARE LLC
DEERFIELD IL 60015 USA

MADE IN USA

PD-2 1.5% Dextrose

Bar Code
(01)00309410411117

NDC 0941-0413-07 (07-25-00-0677) Container Label
NDC 0941-0413-07 (07-25-00-0677) Container Label

L5B5194 5000 mL
NDC 0941-0413-07 (APPROX 150 mL EXCESS)

Vantive Logo

Dianeal PD-2
Peritoneal Dialysis Solution
with 2.5% Dextrose

EACH 100 mL CONTAINS 2.5 g DEXTROSE HYDROUS USP
538 mg SODIUM CHLORIDE USP 448 mg SODIUM LACTATE
25.7 mg CALCIUM CHLORIDE USP 5.08 mg MAGNESIUM
CHLORIDE USP pH 5.2 (4.0 TO 6.5)

mEq/L SODIUM - 132 CALCIUM - 3.5
MAGNESIUM - 0.5
CHLORIDE - 96 LACTATE - 40
OSMOLARITY - 396 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED
ONLY UNDER THE DIRECTION OF A
PHYSICIAN

SEE PACKAGE INSERT FOR DOSAGE INFORMATION

USE AS DIRECTED BY PHYSICIAN

FOR INTRAPERITONEAL
ADMINISTRATION ONLY

CAUTIONS SQUEEZE AND INSPECT INNER BAG
WHICH MAINTAINS PRODUCT STERILITY
DISCARD IF LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT
ROOM TEMPERATURE (25°C/77°F) UNTIL READY TO
USE AVOID EXCESSIVE HEAT SEE INSERT

Ambu-Flex II CONTAINER

VANTIVE US HEALTHCARE LLC
DEERFIELD IL 60015 USA

MADE IN USA

PD-2 2.5% Dextrose

Bar Code
(01) 00309410413074

NDC 0941-0415-06 (07-25-56-591) Container Label
NDC 0941-0415-06 (07-25-56-591) Container Label

L5B5187 2000 mL
NDC 0941-0415-06 (APPROX 80 mL EXCESS)
3000 mL NOMINAL SIZE CONTAINER

Vantive Logo

Dianeal PD-2
Peritoneal Dialysis Solution
with 4.25% Dextrose

EACH 100 mL CONTAINS 4.25 g DEXTROSE HYDROUS USP
538 mg SODIUM CHLORIDE USP 448 mg SODIUM LACTATE
25.7 mg CALCIUM CHLORIDE USP 5.08 mg MAGNESIUM
CHLORIDE USP pH 5.2 (4.0 TO 6.5)

mEq/L SODIUM - 132 CALCIUM - 3.5 MAGNESIUM - 0.5
CHLORIDE - 96 LACTATE - 40
OSMOLARITY - 485 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY UNDER
THE DIRECTION OF A PHYSICIAN

SEE PACKAGE INSERT FOR DOSAGE INFORMATION

USE AS DIRECTED BY PHYSICIAN

FOR INTRAPERITONEAL ADMINISTRATION ONLY

WARNING EXTENSIVE USE OF THIS SOLUTION
DURING ONE PERITONEAL DIALYSIS PROCEDURE CAN
RESULT IN SIGNIFICANT REMOVAL OF WATER FROM
THE PATIENT

CAUTIONS SQUEEZE AND INSPECT INNER BAG
WHICH MAINTAINS PRODUCT STERILITY DISCARD IF
LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT
ROOM TEMPERATURE (25°C/77°F) UNTIL READY TO
USE
AVOID EXCESSIVE HEAT SEE INSERT

Ambu-Flex II CONTAINER

VANTIVE US HEALTHCARE LLC
DEERFIELD IL 60015 USA

MADE IN USA

PD-2 4.25% Dextrose 

NDC 0941-0409-07 (07-25-00-0676) Container Label
NDC 0941-0409-07 (07-25-00-0676) Container Label

L5B4826 5000 mL
NDC 0941-0409-07 (APPROX 150 mL EXCESS)

Vantive Logo

Dianeal
Low Calcium (2.5 mEq/L)
Peritoneal Dialysis Solution
with 1.5% Dextrose

EACH 100 mL CONTAINS 1.5 g DEXTROSE HYDROUS USP
538 mg SODIUM CHLORIDE USP 448 mg SODIUM LACTATE
18.3 mg CALCIUM CHLORIDE USP 5.08 mg MAGNESIUM
CHLORIDE USP pH 5.2 (4.0 TO 6.5)

mEq/L SODIUM - 132 CALCIUM - 2.5
MAGNESIUM - 0.5
CHLORIDE - 95 LACTATE - 40
OSMOLARITY - 344 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY
UNDER THE DIRECTION OF A PHYSICIAN

SEE PACKAGE INSERT FOR DOSAGE INFORMATION

USE AS DIRECTED BY PHYSICIAN

FOR INTRAPERITONEAL
ADMINISTRATION ONLY

CAUTIONS SQUEEZE AND INSPECT INNER BAG
WHICH MAINTAINS PRODUCT STERILITY
DISCARD IF LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP
AT ROOM TEMPERATURE (25°C/77°F) UNTIL READY
TO USE AVOID EXCESSIVE HEAT SEE INSERT

Ambu-Flex II CONTAINER

VANTIVE US HEALTHCARE LLC
DEERFIELD IL 60015 USA

MADE IN USA

Low Calcium 1.5% Dextrose

Bar Code
(01)00309410409077

NDC 0941-0457-08 (07-25-00-0739) Container Label
NDC 0941-0457-08 (07-25-00-0739) Container Label

L5B9727 2000 mL
NDC 0941-0457-08 (APPROX 80 mL EXCESS)
3000 mL NOMINAL SIZE CONTANER

Vantive Logo

Dianeal
Low Calcium (2.5 mEq/L)
Peritoneal Dialysis Solution
with 2.5% Dextrose

EACH 100 mL CONTAINS 2.5 g DEXTROSE
HYDROUS USP 538 mg SODIUM CHLORIDE
USP 448 mg SODIUM LACTATE 18.3 mg
CALCIUM CHLORIDE USP 5.08 mg MAGNESIUM
CHLORIDE USP pH 5.2 (4.0 TO 6.5)

mEq/L SODIUM - 132 CALCIUM - 2.5
MAGNESIUM - 0.5 CHLORIDE - 95
LACTATE – 40 OSMOLARITY - 395 mOsmol/L
(CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY
UNDER THE DIRECTION OF A PHYSICIAN

SEE PACKAGE INSERT FOR DOSAGE
INFORMATION

USE AS DIRECTED BY PHYSICIAN

FOR INTRAPERITONEAL ADMINISTRATION ONLY

CAUTIONS SQUEEZE AND INSPECT INNER BAG
WHICH MAINTAINS PRODUCT STERILITY
DISCARD IF LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT
ROOM TEMPERATURE (25°C/77°F) UNTIL READY TO
USE AVOID EXCESSIVE HEAT SEE INSERT

Ambu-Flex II CONTAINER

VANTIVE US HEALTHCARE LLC
DEERFIELD IL 60015 USA

MADE IN USA

Low Calcium 2.5% Dextrose

Bar Code
(01)00309410457085

NDC 0941-0459-08 Container Label
NDC 0941-0459-08 Container Label

L5B9747 2000 mL
NDC 0941-0459-08 (APPROX 80 mL EXCESS)
3000 mL NOMINAL SIZE CONTAINER

Vantive Logo

Dianeal
Low Calcium (2.5 mEq/L)
Peritoneal Dialysis Solution
with 4.25% Dextrose

EACH 100 mL CONTAINS 4.25 g DEXTROSE HYDROUS USP
538 mg SODIUM CHLORIDE USP 448 mg SODIUM LACTATE
18.3 mg CALCIUM CHLORIDE USP 5.08 mg MAGNESIUM
CHLORIDE USP pH 5.2 (4.0 TO 6.5)

mEq/L SODIUM - 132 CALCIUM - 2.5 MAGNESIUM - 0.5
CHLORIDE - 95 LACTATE - 40
OSMOLARITY - 483 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY UNDER
THE DIRECTION OF A PHYSICIAN

SEE PACKAGE INSERT FOR DOSAGE INFORMATION

USE AS DIRECTED BY PHYSICIAN

FOR INTRAPERITONEAL ADMINISTRATION ONLY

CAUTIONS SQUEEZE AND INSPECT INNER BAG
WHICH MAINTAINS PRODUCT STERILITY DISCARD IF
LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT
ROOM TEMPERATURE (25°C/77°F) UNTIL READY TO
USE
AVOID EXCESSIVE HEAT SEE INSERT

Ambu-Flex II CONTAINER PL 146 PLASTIC

VANTIVE US HEALTHCARE LLC
DEERFIELD IL 60015 USA

MADE IN USA

Low Calcium 4.25% Dextrose

NDC 0941-0426-52 Container Label
NDC 0941-0426-52 Container Label

5B9866 2000 mL
NDC 0941-0426-52 (APPROX 80 mL EXCESS)

Vantive Logo

Dianeal PD-2
Peritoneal Dialysis Solution
with 1.5% Dextrose

EACH 100 mL CONTAINS 1.5 g DEXTROSE HYDROUS USP
538 mg SODIUM CHLORIDE USP 448 mg SODIUM
LACTATE 25.7 mg CALCIUM CHLORIDE USP 5.08 mg
MAGNESIUM CHLORIDE USP pH 5.2 (4.0 TO 6.5)

mEq/L SODIUM - 132 CALCIUM - 3.5 MAGNESIUM - 0.5
CHLORIDE - 96 LACTATE - 40
OSMOLARITY - 346 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY
UNDER THE DIRECTION OF A PHYSICIAN

READ PACKAGE INSERT FOR FULL INFORMATION

FOR INTRAPERITONEAL ADMINISTRATION ONLY

DOSAGE AS DIRECTED BY PHYSICIAN

CAUTIONS SQUEEZE AND INSPECT INNER BAG
WHICH MAINTAINS PRODUCT STERILITY DISCARD
IF LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT
ROOM TEMPERATURE (25°C/77°F) UNTIL READY TO
USE AVOID EXCESSIVE HEAT SEE INSERT

UltraBag CONTAINER

VANTIVE US HEALTHCARE LLC
DEERFIELD IL 60015 USA

MADE IN USA

PD-2 1.5% Dextrose

NDC 0941-0427-52 Container Label
NDC 0941-0427-52 Container Label

5B9876 2000 mL
NDC 0941-0427-52 (APPROX 80 mL EXCESS)

Vantive Logo

Dianeal PD-2
Peritoneal Dialysis Solution
with 2.5% Dextrose

EACH 100 mL CONTAINS 2.5 g DEXTROSE HYDROUS USP
538 mg SODIUM CHLORIDE USP 448 mg SODIUM
LACTATE 25.7 mg CALCIUM CHLORIDE USP 5.08 mg
MAGNESIUM CHLORIDE USP pH 5.2 (4.0 TO 6.5)

mEq/L SODIUM - 132 CALCIUM - 3.5 MAGNESIUM - 0.5
CHLORIDE - 96 LACTATE - 40
OSMOLARITY - 396 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY UNDER
THE DIRECTION OF A PHYSICIAN

READ PACKAGE INSERT FOR FULL INFORMATION

FOR INTRAPERITONEAL ADMINISTRATION ONLY

DOSAGE AS DIRECTED BY PHYSICIAN

CAUTIONS SQUEEZE AND INSPECT INNER BAG
WHICH MAINTAINS PRODUCT STERILITY DISCARD
IF LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP
AT ROOM TEMPERATURE (25°C/77°F) UNTIL
READY TO USE

AVOID EXCESSIVE HEAT SEE INSERT

UltraBag CCONTAINER

VANTIVE US HEALTHCARE LLC
DEERFIELD IL 60015 USA

MADE IN USA

PD-2 2.5% Dextrose

NDC 0941-0429-52 Container Label
NDC 0941-0429-52 Container Label

5B9896 2000 mL
NDC 0941-0429-52 (APPROX 80 mL EXCESS)

Vantive Logo

Dianeal PD-2
Peritoneal Dialysis Solution
with 4.25% Dextrose

EACH 100 mL CONTAINS 4.25 g DEXTROSE HYDROUS USP
538 mg SODIUM CHLORIDE USP 448 mg SODIUM LACTATE
25.7 mg CALCIUM CHLORIDE USP 5.08 mg MAGNESIUM
CHLORIDE USP pH 5.2 (4.0 TO 6.5)

mEq/L SODIUM - 132 CALCIUM - 3.5 MAGNESIUM - 0.5
CHLORIDE - 96 LACTATE - 40
OSMOLARITY - 485 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY
UNDER THE DIRECTION OF A PHYSICIAN

READ PACKAGE INSERT FOR FULL INFORMATION

WARNING EXTENSIVE USE OF THIS SOLUTION DURING
ONE PERITONEAL DIALYSIS PROCEDURE CAN RESULT IN
SIGNIFICANT REMOVAL OF WATER FROM THE PATIENT

FOR INTRAPERITONEAL ADMINISTRATION ONLY

DOSAGE AS DIRECTED BY A PHYSICIAN

CAUTIONS SQUEEZE AND INSPECT INNER BAG
WHICH MAINTAINS PRODUCT STERILITY DISCARD IF
LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION
Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT
ROOM TEMPERATURE (25°C/77°F) UNTIL READY TO
USE AVOID EXCESSIVE HEAT SEE INSERT

UltraBag CONTAINER

VANTIVE US HEALTHCARE LLC
DEERFIELD IL 60015 USA

MADE IN USA

PD-2 4.25% Dextrose

NDC 0941-0424-52 Container Label
NDC 0941-0424-52 Container Label

5B9766 2000 mL
NDC 0941-0424-52 (APPROX 80 mL EXCESS)

Vantive Logo

Dianeal
Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution
with 1.5% Dextrose

EACH 100 mL CONTAINS 1.5 g DEXTROSE HYDROUS USP
538 mg SODIUM CHLORIDE USP 448 mg SODIUM
LACTATE 18.3 mg CALCIUM CHLORIDE USP 5.08 mg
MAGNESIUM CHLORIDE USP pH 5.2 (4.0 TO 6.5)

mEq/L SODIUM - 132 CALCIUM - 2.5
MAGNESIUM - 0.5
CHLORIDE - 95 LACTATE - 40
OSMOLARITY - 344 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY
UNDER THE DIRECTION OF A PHYSICIAN

READ PACKAGE INSERT FOR FULL
INFORMATION

FOR INTRAPERITONEAL
ADMINISTRATION ONLY

DOSAGE AS DIRECTED BY PHYSICIAN

CAUTIONS SQUEEZE AND INSPECT INNER BAG
WHICH MAINTAINS PRODUCT STERILITY
DISCARD IF LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT
ROOM TEMPERATURE (25°C/77°F) UNTIL READY TO
USE AVOID EXCESSIVE HEAT SEE INSERT

UltraBag CONTAINER

VANTIVE US HEALTHCARE LLC
DEERFIELD IL 60015 USA

MADE IN USA

Low Calcium 1.5% Dextrose

Barcode
(01) 00309410424520

NDC 0941-0430-52 (07-25-00-0683) Container Label
NDC 0941-0430-52 (07-25-00-0683) Container Label

5B9776 2000 mL
NDC 0941-0430-52 (APPROX 80 mL EXCESS)

Vantive Logo

Dianeal
Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution
with 2.5% Dextrose

EACH 100 mL CONTAINS 1.5 g DEXTROSE HYDROUS USP
538 mg SODIUM CHLORIDE USP 448 mg SODIUM LACTATE
18.3 mg CALCIUM CHLORIDE USP 5.08 mg MAGNESIUM
CHLORIDE USP pH 5.2 (4.0 TO 6.5)

mEq/L SODIUM - 132 CALCIUM - 2.5
MAGNESIUM - 0.5
CHLORIDE - 95 LACTATE - 40
OSMOLARITY - 395 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY
UNDER THE DIRECTION OF A PHYSICIAN

READ PACKAGE INSERT FOR FULL
INFORMATION

FOR INTRAPERITONEAL
ADMINISTRATION ONLY

DOSAGE AS DIRECTED BY PHYSICIAN

CAUTIONS SQUEEZE AND INSPECT INNER BAG
WHICH MAINTAINS PRODUCT STERILITY DISCARD
IF LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT
ROOM TEMPERATURE (25°C/77°F) UNTIL READY TO
USE AVOID EXCESSIVE HEAT SEE INSERT

UltraBag CONTAINER

VANTIVE US HEALTHCARE LLC
DEERFIELD IL 60015 USA

MADE IN USA

Low Calcium 2.5% Dextrose

Barcode
(01) 00309410430521

NDC 0941-0433-52 Container Label
NDC 0941-0433-52 Container Label

5B9796 2000 mL
NDC 0941-0433-52 (APPROX 80 mL EXCESS)

Vantive Logo

Dianeal
Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution
with 4.25% Dextrose

EACH 100 mL CONTAINS 4.25 g DEXTROSE HYDROUS USP
538 mg SODIUM CHLORIDE USP 448 mg SODIUM LACTATE
18.3 mg CALCIUM CHLORIDE USP 5.08 mg MAGNESIUM
CHLORIDE USP pH 5.2 (4.0 TO 6.5)

mEq/L SODIUM - 132 CALCIUM - 2.5 MAGNESIUM - 0.5
CHLORIDE - 95 LACTATE - 40
OSMOLARITY - 483 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY
UNDER THE DIRECTION OF A PHYSICIAN

READ PACKAGE INSERT FOR FULL INFORMATION

WARNING EXTENSIVE USE OF THIS SOLUTION DURING
ONE PERITONEAL DIALYSIS PROCEDURE CAN RESULT IN
SIGNIFICANT REMOVAL OF WATER FROM THE PATIENT

FOR INTRAPERITONEAL ADMINISTRATION ONLY

DOSAGE AS DIRECTED BY PHYSICIAN

CAUTIONS SQUEEZE AND INSPECT INNER BAG WHICH
MAINTAINS PRODUCT STERILITY DISCARD IF LEAKS
ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT ROOM
TEMPERATURE (25°C/77°F) UNTIL READY TO USE
AVOID EXCESSIVE HEAT SEE INSERT

UltraBag CONTAINER

VANTIVE US HEALTHCARE LLC
DEERFIELD IL 60015 USA

MADE IN USA

Low Calcium 4.25% Dextrose

NDC 0941-0484-01 Container Label
NDC 0941-0484-01 Container Label

LOT EXPIRY

EZPB5245R
NDC 0941-0484-01

5000 mL
(APPROX 135 mL EXCESS)

Vantive Logo

Dianeal
Low Calcium (2.5 mEq/L)
Peritoneal Dialysis Solution
with 1.5% Dextrose

EACH 100 mL CONTAINS 1.5 g DEXTROSE HYDROUS 538 mg SODIUM CHLORIDE
448 mg SODIUM LACTATE 18.4 mg CALCIUM CHLORIDE 5.08 mg MAGNESIUM CHLORIDE
pH 5.0 to 6.5

mEq/L SODIUM – 132 CALCIUM – 2.5 MAGNESIUM – 0.5 CHLORIDE – 95 LACTATE – 40
OSMOLARITY – 344 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY UNDER THE DIRECTION OF A PHYSICIAN

SEE PACKAGE INSERT FOR DOSAGE INFORMATION

USE AS DIRECTED BY PHYSICIAN

FOR INTRAPERITONEAL ADMINISTRATION ONLY

CAUTIONS SQUEEZE AND INSPECT INNER BAG WHICH
MAINTAINS PRODUCT STERILITY DISCARD IF LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT ROOM TEMPERATURE (25°C/77°F) UNTIL READY
TO USE AVOID EXCESSIVE HEAT SEE INSERT
PLASTIC CONTAINER WITH BLUE PULL TIP

VANTIVE US HEALTHCARE LLC DEERFIELD IL 60015 USA

MADE IN IRELAND

CB-35-05-678

Low Calcium 1.5% Dextrose

Barcode
(01) 00309410484012

NDC 0941-0487-01 Container Label
NDC 0941-0487-01 Container Label

LOT EXPIRY

EZPB5255R
NDC 0941-0487-01

5000 mL
(APPROX 135 mL EXCESS)

Vantive Logo

Dianeal
Low Calcium (2.5 mEq/L)
Peritoneal Dialysis Solution
with 2.5% Dextrose

EACH 100 mL CONTAINS 2.5 g DEXTROSE HYDROUS 538 mg SODIUM CHLORIDE
448 mg SODIUM LACTATE 18.4 mg CALCIUM CHLORIDE 5.08 mg MAGNESIUM CHLORIDE
pH 5.0 to 6.5

mEq/L SODIUM – 132 CALCIUM – 2.5 MAGNESIUM – 0.5 CHLORIDE – 95 LACTATE – 40
OSMOLARITY – 395 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY UNDER THE DIRECTION OF A PHYSICIAN

SEE PACKAGE INSERT FOR DOSAGE INFORMATION

USE AS DIRECTED BY PHYSICIAN

FOR INTRAPERITONEAL ADMINISTRATION ONLY

  • CAUTIONS SQUEEZE AND INSPECT INNER BAG WHICH MAINTAINS PRODUCT STERILITY
    DISCARD IF LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT ROOM TEMPERATURE (25ºC/77ºF) UNTIL READY TO USE AVOID EXCESSIVE HEAT SEE INSERT

PLASTIC CONTAINER WITH BLUE PULL TIP

VANTIVE US HEALTHCARE LLC DEERFIELD IL 60015 USA

MADE IN IRELAND

CB-35-05-676

Low Calcium 2.5% Dextrose

Barcode
(01) 00309410487013

NDC 0941-0490-01 Container Label
NDC 0941-0490-01 Container Label

LOT EXPIRY

EZPB5265R
NDC 0941-0490-01

5000 mL
(APPROX 135 mL EXCESS)

Vantive Logo

Dianeal
Low Calcium (2.5 mEq/L)
Peritoneal Dialysis Solution
with 4.25% Dextrose

EACH 100 mL CONTAINS 4.25 g DEXTROSE HYDROUS 538 mg SODIUM CHLORIDE
448 mg SODIUM LACTATE 18.4 mg CALCIUM CHLORIDE 5.08 mg MAGNESIUM CHLORIDE
pH 5.0 to 6.5


mEq/L SODIUM – 132 CALCIUM – 2.5 MAGNESIUM – 0.5 CHLORIDE – 95 LACTATE – 40
OSMOLARITY – 483 mOsmol/L (CALC)

STERILE NONPYROGENIC

POTASSIUM CHLORIDE TO BE ADDED ONLY UNDER THE DIRECTION OF A PHYSICIAN

SEE PACKAGE INSERT FOR DOSAGE INFORMATION

USE AS DIRECTED BY PHYSICIAN

FOR INTRAPERITONEAL ADMINISTRATION ONLY

WARNING EXTENSIVE USE OF THIS SOLUTION DURING ONE PERITONEAL DIALYSIS
PROCEDURE CAN RESULT IN SIGNIFICANT REMOVAL OF WATER FROM THE PATIENT

  • CAUTIONS SQUEEZE AND INSPECT INNER BAG WHICH MAINTAINS PRODUCT STERILITY DISCARD IF LEAKS ARE FOUND

DO NOT USE UNLESS SOLUTION IS CLEAR

DISCARD UNUSED PORTION

Rx ONLY

STORE UNIT IN MOISTURE BARRIER OVERWRAP AT ROOM TEMPERATURE (25ºC/77ºF) UNTIL READY
TO USE AVOID EXCESSIVE HEAT SEE INSERT

VANTIVE US HEALTHCARE LLC DEERFIELD IL 60015 USA

MADE IN IRELAND

CB-35-05-677

Low Calcium 4.25% Dextrose

Barcode
(01) 00309410490013

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6e3c022f-0786-43f1-8857-edff89d5153fProduct name120260309
95250459-30e4-45c1-b08a-993044f49109Product name220250805
bee4fa8d-8d82-423a-a0b5-40a89dd13a99Product name120250618
e0d2eb29-08bd-4bba-90d1-c91c68a38767Product name420250516
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2Product name520250304
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
a21a21e5-f36d-4c1f-8918-def921b8f7e3Product name320250124
bed0530e-f939-4541-956b-6928a2f6404fProduct name120241008
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name620240814
fb7ab793-2c12-4079-b100-a64f73bef25aProduct name420240712
334fe8d2-68fb-4331-a576-420e302ec069Product name720240320
efd58652-cb8f-4018-91ca-4b0eb2ff729fProduct name720240226
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
b0cbf770-6cc3-4aa4-9158-755110c2b9f7Product name220230717
cb89b86a-369e-4204-8910-ae797c503af3Product name120230706
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
e2db08c6-133f-4f4f-afb4-e90a2418d6f6Product name120230320
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
2641ccb3-721d-4fbf-9f2f-ca2f18157a62Product name320210309
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
e92765c1-be81-432a-b909-1b10777ec378Product name120190208
11ed6f83-cdd2-4637-8379-b1a1d3ae3cdeProduct name120181101
d4880ace-a516-8c47-8dfd-73a4ba5887d7Product name220180830
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
86c45a79-b9f0-4476-a27c-6e10db098497Product name120180125
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name220171212
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
e7e58cd3-cacb-49df-8d34-1ee335614abbProduct name120150609
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
0441a8f5-3835-497c-aedd-bc78cba56b2aProduct name120150317
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0941-0459-01ML - Milliliter0941-0459ff840e6b-f55f-4e15-9d2b-ad77587546cd12012-07-24
0941-0459-02ML - Milliliter0941-0459de7f6c41-b67c-48a7-95e0-ed6e3b98709012012-07-24
0941-0459-05ML - Milliliter0941-0459f121f2bd-436f-4e2d-88a9-c8bca79c96e612012-07-24
0941-0459-08ML - Milliliter0941-0459cd5248ce-4452-4d35-994b-931e302b10fb12012-07-24
0941-0459-25ML - Milliliter0941-0459909073f9-dcbe-4142-a635-e22014c7f32912012-07-24
0941-0459-28ML - Milliliter0941-0459a2aafbf3-99b1-4a0c-96ff-e6c4eb26087812012-07-24
0941-0459-47ML - Milliliter0941-0459ecc42dfe-aadb-4292-bcf9-40bfb8399ccf12012-07-24
0941-0459-49ML - Milliliter0941-0459dd65c6cc-7165-406a-a71e-0eca2086ef1412012-07-24
0941-0415-01ML - Milliliter0941-0415997bd3b9-59cd-44b7-9531-dea143dfa54012012-07-24
0941-0415-04ML - Milliliter0941-04151f344912-b878-474e-b479-47eac11db71612012-07-24
0941-0415-05ML - Milliliter0941-0415e539a2bd-b201-4312-b1e6-d6c5e29ad8f112012-07-24
0941-0415-06ML - Milliliter0941-041534328a32-4067-4684-a051-8f17cf8c9fab12012-07-24
0941-0415-07ML - Milliliter0941-04155375fd78-eab7-4346-b902-d2178fd8350c12012-07-24
0941-0415-25ML - Milliliter0941-0415ac3d22e9-e425-4b16-986a-29e799c90e6e12012-07-24
0941-0415-28ML - Milliliter0941-041549c2a655-6210-4cef-8ff2-ed72ef2cabfb12012-07-24
0941-0415-43ML - Milliliter0941-04155e8c4903-185c-4a15-b321-6d1083a705e012012-07-24
0941-0415-47ML - Milliliter0941-041591adfe88-26d7-4c6d-ab6f-aedb6ab5d27312012-07-24
0941-0415-49ML - Milliliter0941-04155033213f-0d71-4a8a-84be-c4e09e11f52a12012-07-24
0941-0409-01ML - Milliliter0941-04090dee8973-f8c1-4367-a8c9-2fa88b219e4412012-07-24
0941-0409-05ML - Milliliter0941-040927c4c97f-6893-4994-b247-353c6337b59b12012-07-24
0941-0409-06ML - Milliliter0941-04090b59f8b3-c4c1-4fb6-baba-a37829df68a912012-07-24
0941-0409-07ML - Milliliter0941-0409b51377b4-c88f-4804-a8dd-df90a03065b212012-07-24
0941-0409-27ML - Milliliter0941-04091c9758e3-6ae8-4d4d-9b74-e7ed6c80224012012-07-24
0941-0409-28ML - Milliliter0941-0409aef58de3-06d1-4070-98ef-132c1855cd0e12012-07-24
0941-0409-36ML - Milliliter0941-0409143d9244-c45d-4d96-b02e-b270c54178a312013-02-13
0941-0409-49ML - Milliliter0941-04091cd8d767-cd37-40a2-815b-92f3245c2a3f12012-07-24
0941-0457-01ML - Milliliter0941-045778d3c231-c764-4368-aa12-eda7328d1cc412012-07-24
0941-0457-02ML - Milliliter0941-0457772b1558-d81b-474d-9fd9-48fd077fe0d012012-07-24
0941-0457-05ML - Milliliter0941-0457897f5c74-6fbd-44d0-a02f-694f14ba49d812012-07-24
0941-0457-08ML - Milliliter0941-045738024003-d177-412e-ae77-bd3b89e22ae712012-07-24
0941-0457-25ML - Milliliter0941-0457ec1bb26e-ee92-487d-8d82-b17591eacbb812012-07-24
0941-0457-28ML - Milliliter0941-0457409ebc0c-e243-42b8-8219-d3b448dc2b4612012-07-24
0941-0457-47ML - Milliliter0941-0457f6f7adba-9981-4b8e-8a21-7a1d6c9ded5312012-07-24
0941-0457-49ML - Milliliter0941-045781736bb3-acf6-4c1f-8e1b-01c7e8c9e27f12012-07-24
0941-0411-04ML - Milliliter0941-04116e120ef9-80db-4235-8f6c-3e4473f6453612012-07-24
0941-0411-05ML - Milliliter0941-0411f0d2d89a-8663-4dd0-9f57-9808d96a39d412012-07-24
0941-0411-06ML - Milliliter0941-0411d2f8dbc5-d92d-45b4-9c1f-e3cf15b9cbcf12012-07-24
0941-0411-07ML - Milliliter0941-0411b00fd031-75e4-4985-8308-6e14e63ee93e12012-07-24
0941-0411-11ML - Milliliter0941-0411a874f663-3bee-4de0-bb88-35669535795012012-07-24
0941-0411-25ML - Milliliter0941-04111f0369d8-717e-49b8-9ba1-98d4c742193b12012-07-24
0941-0411-28ML - Milliliter0941-04112112469e-1311-440c-99c6-53151282bab912012-07-24
0941-0411-43ML - Milliliter0941-04115354bebb-6bf4-4885-8d34-6bc249e33f5c12012-07-24
0941-0411-46ML - Milliliter0941-041184425bef-8e25-42a7-b3bf-f95ed6d9118212012-07-24
0941-0411-49ML - Milliliter0941-041186d56656-de67-4e96-9058-a61769eb8a9012012-07-24
0941-0413-01ML - Milliliter0941-04134fc1dcd4-3f9a-45ef-a2d6-41cc3b39d55512012-07-24
0941-0413-04ML - Milliliter0941-0413eeb2f34a-f659-4464-9d1c-28d344219d7f12012-07-24
0941-0413-05ML - Milliliter0941-041322a8068e-b09e-4ae1-840d-a45bf35c357412012-07-24
0941-0413-06ML - Milliliter0941-04130114a3c1-1164-4e50-8e38-bab539b8e1f012012-07-24
0941-0413-07ML - Milliliter0941-0413c2368b25-69db-4e0a-ad62-e1a04a2ea6eb12012-07-24
0941-0413-25ML - Milliliter0941-041396977a6e-03da-4936-b752-4ef4a84cb5da12012-07-24
0941-0413-28ML - Milliliter0941-041362b0adc3-c8c2-49df-9137-70a80626300b12012-07-24
0941-0413-43ML - Milliliter0941-0413214df8f3-7376-480d-b886-da08e71189b812012-07-24
0941-0413-47ML - Milliliter0941-04137d34cc4d-7178-45fa-b40c-209a4428faa712012-07-24
0941-0413-49ML - Milliliter0941-0413732054f6-1d80-4b22-8a68-c3fbddafd48812012-07-24
0941-0426-52ML - Milliliter0941-0426c4a25fc2-fc45-42e9-a2dd-d35cef04624d12013-02-13
0941-0426-53ML - Milliliter0941-0426c0a39c6d-f9b0-4bbc-85c7-6a269276201c12013-02-13
0941-0426-55ML - Milliliter0941-04269ea22e13-0742-4f53-a264-260d1ce2258012013-02-13
0941-0427-52ML - Milliliter0941-04276dd6ebf0-029c-47ea-90df-d57f4ec26c5612013-02-13
0941-0427-53ML - Milliliter0941-04271c5c8074-5f33-4769-ae1d-c4b9493a50fe12013-02-13
0941-0427-55ML - Milliliter0941-04277b683c5e-a463-48cc-9885-ae37085a427d12013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
CALCIUM CHLORIDEACTIVE INGREDIENTM4I0D6VV5M14
DEXTROSE MONOHYDRATEACTIVE INGREDIENTLX22YL083G14
MAGNESIUM CHLORIDEACTIVE INGREDIENT02F3473H9O14
SODIUM CHLORIDEACTIVE INGREDIENT451W47IQ8X14
SODIUM LACTATEACTIVE INGREDIENTTU7HW0W0QT14
ANHYDROUS DEXTROSEACTIVE MOIETY5SL0G7R0OK14
CALCIUM CATIONACTIVE MOIETY2M83C4R6ZB14
CHLORIDE IONACTIVE MOIETYQ32ZN4869814
LACTIC ACIDACTIVE MOIETY33X04XA5AT14
SODIUM CATIONACTIVE MOIETYLYR4M0NH3714
WATERINACTIVE INGREDIENT059QF0KO0R14

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 3 · 90 matching rows.

Source Document#

Source XML · Source PDF

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
372026-04-16full-release2026-05-31 22:16:07
362025-10-31monthly-update2026-06-03 17:53:48

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 3 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 15 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N017512-001DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEALApproved before 1982
N017512-002DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEALApproved before 1982
N017512-003DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEALApproved before 1982
N017512-004DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, Approved before 1982
N017512-005DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, Approved before 1982
N017512-006DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, Approved before 1982
N017512-007DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1984-07-09
N017512-008DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1984-07-09
N017512-009DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1984-07-09
N017512-010DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;3.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1985-11-18
N017512-011DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1985-11-18
N017512-012DIANEAL LOW CALCIUM W/DEXTROSE 1.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1989-01-10
N017512-013DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1990-07-11
N017512-014DIANEAL LOW CALCIUM W/DEXTROSE 3.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1990-07-11
N017512-015DIANEAL LOW CALCIUM W/DEXTROSE 4.25% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1990-07-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 6 matching rows.

Application-product, TE code table
Application-productTE code
N017512-004AT
N017512-005AT
N017512-006AT
N017512-012AT
N017512-013AT
N017512-015AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 17 · 671 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N017512-001DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEALApproved before 1982d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-002DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEALApproved before 1982d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-003DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEALApproved before 1982d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-004DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, Approved before 1982d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-005DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, Approved before 1982d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-006DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, Approved before 1982d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-007DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1984-07-09d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-008DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1984-07-09d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-009DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1984-07-09d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-010DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER25.7MG/100ML;3.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1985-11-18d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-011DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER25.7MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1985-11-18d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-012DIANEAL LOW CALCIUM W/DEXTROSE 1.5% IN PLASTIC CONTAINER18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1989-01-10d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-013DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1990-07-11d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-014DIANEAL LOW CALCIUM W/DEXTROSE 3.5% IN PLASTIC CONTAINER18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1990-07-11d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-015DIANEAL LOW CALCIUM W/DEXTROSE 4.25% IN PLASTIC CONTAINER18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1990-07-11d4dbc9d85df4…
2026-10-15 13:18:302026-09N017512-001DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEALApproved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N017512-002DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEALApproved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N017512-003DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEALApproved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N017512-004DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, Approved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N017512-005DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, Approved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N017512-006DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, Approved before 1982c2088c7a36db…
2026-10-15 13:18:302026-09N017512-007DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1984-07-09c2088c7a36db…
2026-10-15 13:18:302026-09N017512-008DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1984-07-09c2088c7a36db…
2026-10-15 13:18:302026-09N017512-009DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1984-07-09c2088c7a36db…
2026-10-15 13:18:302026-09N017512-010DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER25.7MG/100ML;3.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1985-11-18c2088c7a36db…
2026-10-15 13:18:302026-09N017512-011DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER25.7MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1985-11-18c2088c7a36db…
2026-10-15 13:18:302026-09N017512-012DIANEAL LOW CALCIUM W/DEXTROSE 1.5% IN PLASTIC CONTAINER18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1989-01-10c2088c7a36db…
2026-10-15 13:18:302026-09N017512-013DIANEAL LOW CALCIUM W/DEXTROSE 2.5% IN PLASTIC CONTAINER18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1990-07-11c2088c7a36db…
2026-10-15 13:18:302026-09N017512-014DIANEAL LOW CALCIUM W/DEXTROSE 3.5% IN PLASTIC CONTAINER18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1990-07-11c2088c7a36db…
2026-10-15 13:18:302026-09N017512-015DIANEAL LOW CALCIUM W/DEXTROSE 4.25% IN PLASTIC CONTAINER18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1990-07-11c2088c7a36db…
2026-09-14 22:38:342026-08N017512-001DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEALApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N017512-002DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEALApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N017512-003DIANEAL 137 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEALApproved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N017512-004DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, Approved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N017512-005DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, Approved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N017512-006DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, Approved before 198284e616aacf4f…
2026-09-14 22:38:342026-08N017512-007DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1984-07-0984e616aacf4f…
2026-09-14 22:38:342026-08N017512-008DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1984-07-0984e616aacf4f…
2026-09-14 22:38:342026-08N017512-009DIANEAL PD-1 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1984-07-0984e616aacf4f…
2026-09-14 22:38:342026-08N017512-010DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER25.7MG/100ML;3.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100MLSOLUTION / INTRAPERITONEAL1985-11-1884e616aacf4f…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 8 · 302 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N017512-004AT1d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-005AT1d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-006AT1d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-012AT1d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-013AT1d4dbc9d85df4…
2026-11-14 07:37:172026-10N017512-015AT1d4dbc9d85df4…
2026-10-15 13:18:302026-09N017512-004AT1c2088c7a36db…
2026-10-15 13:18:302026-09N017512-005AT1c2088c7a36db…
2026-10-15 13:18:302026-09N017512-006AT1c2088c7a36db…
2026-10-15 13:18:302026-09N017512-012AT1c2088c7a36db…
2026-10-15 13:18:302026-09N017512-013AT1c2088c7a36db…
2026-10-15 13:18:302026-09N017512-015AT1c2088c7a36db…
2026-09-14 22:38:342026-08N017512-004AT184e616aacf4f…
2026-09-14 22:38:342026-08N017512-005AT184e616aacf4f…
2026-09-14 22:38:342026-08N017512-006AT184e616aacf4f…
2026-09-14 22:38:342026-08N017512-012AT184e616aacf4f…
2026-09-14 22:38:342026-08N017512-013AT184e616aacf4f…
2026-09-14 22:38:342026-08N017512-015AT184e616aacf4f…
2026-08-18 06:07:402026-07N017512-004AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N017512-005AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N017512-006AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N017512-012AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N017512-013AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N017512-015AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N017512-004AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017512-005AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017512-006AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017512-012AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017512-013AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017512-015AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017512-004AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017512-005AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017512-006AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017512-012AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017512-013AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017512-015AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08N017512-004AT16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N017512-005AT16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N017512-006AT16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N017512-012AT16a471c1ec25d…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04
N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04
N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
N020163-001AT
N020163-002AT
N020163-003AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 135 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04d4dbc9d85df4…
2026-11-14 07:37:172026-10N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04d4dbc9d85df4…
2026-11-14 07:37:172026-10N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04d4dbc9d85df4…
2026-10-15 13:18:302026-09N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04c2088c7a36db…
2026-10-15 13:18:302026-09N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04c2088c7a36db…
2026-10-15 13:18:302026-09N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04c2088c7a36db…
2026-09-14 22:38:342026-08N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0484e616aacf4f…
2026-09-14 22:38:342026-08N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0484e616aacf4f…
2026-09-14 22:38:342026-08N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0484e616aacf4f…
2026-08-18 06:07:402026-07N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04caaa826d4ba7…
2026-08-18 06:07:402026-07N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04caaa826d4ba7…
2026-08-18 06:07:402026-07N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0431067a03dcf5…
2025-08-23 18:47 UTC2025-08N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-046a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-046a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-046a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-042680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-042680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-042680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-045bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-045bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-045bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020163-002DIANEAL PD-2 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER25.7MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020163-003DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER25.7MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020163-001DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER25.7MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04d06236e962d9…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 135 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N020163-001AT1d4dbc9d85df4…
2026-11-14 07:37:172026-10N020163-002AT1d4dbc9d85df4…
2026-11-14 07:37:172026-10N020163-003AT1d4dbc9d85df4…
2026-10-15 13:18:302026-09N020163-001AT1c2088c7a36db…
2026-10-15 13:18:302026-09N020163-002AT1c2088c7a36db…
2026-10-15 13:18:302026-09N020163-003AT1c2088c7a36db…
2026-09-14 22:38:342026-08N020163-001AT184e616aacf4f…
2026-09-14 22:38:342026-08N020163-002AT184e616aacf4f…
2026-09-14 22:38:342026-08N020163-003AT184e616aacf4f…
2026-08-18 06:07:402026-07N020163-001AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N020163-002AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N020163-003AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020163-001AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020163-002AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020163-003AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020163-001AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020163-002AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020163-003AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08N020163-001AT16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020163-002AT16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020163-003AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020163-001AT1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020163-002AT1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020163-003AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020163-001AT1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020163-002AT1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020163-003AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020163-001AT103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020163-002AT103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020163-003AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020163-001AT12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020163-002AT12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020163-003AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020163-001AT15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020163-002AT15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020163-003AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020163-001AT1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020163-002AT1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020163-003AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020163-001AT1d06236e962d9…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020183-001DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04
N020183-002DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04
N020183-003DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1992-12-04
N020183-004DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
N020183-001AT
N020183-002AT
N020183-004AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 180 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N020183-001DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04d4dbc9d85df4…
2026-11-14 07:37:172026-10N020183-002DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04d4dbc9d85df4…
2026-11-14 07:37:172026-10N020183-003DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1992-12-04d4dbc9d85df4…
2026-11-14 07:37:172026-10N020183-004DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04d4dbc9d85df4…
2026-10-15 13:18:302026-09N020183-001DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04c2088c7a36db…
2026-10-15 13:18:302026-09N020183-002DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04c2088c7a36db…
2026-10-15 13:18:302026-09N020183-003DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1992-12-04c2088c7a36db…
2026-10-15 13:18:302026-09N020183-004DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04c2088c7a36db…
2026-09-14 22:38:342026-08N020183-001DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0484e616aacf4f…
2026-09-14 22:38:342026-08N020183-002DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0484e616aacf4f…
2026-09-14 22:38:342026-08N020183-003DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1992-12-0484e616aacf4f…
2026-09-14 22:38:342026-08N020183-004DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0484e616aacf4f…
2026-08-18 06:07:402026-07N020183-001DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04caaa826d4ba7…
2026-08-18 06:07:402026-07N020183-002DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04caaa826d4ba7…
2026-08-18 06:07:402026-07N020183-003DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1992-12-04caaa826d4ba7…
2026-08-18 06:07:402026-07N020183-004DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020183-001DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020183-002DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020183-003DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1992-12-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020183-004DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020183-001DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020183-002DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020183-003DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1992-12-0431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020183-004DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0431067a03dcf5…
2025-08-23 18:47 UTC2025-08N020183-001DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-046a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020183-002DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-046a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020183-003DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1992-12-046a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020183-004DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-046a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020183-001DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020183-002DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020183-003DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1992-12-04fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020183-004DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020183-001DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020183-002DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020183-003DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1992-12-04b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020183-004DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-04b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020183-001DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER18.3MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020183-002DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER18.3MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020183-003DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER18.3MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALRLD1992-12-0403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020183-004DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER18.3MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD1992-12-0403ed91905a0d…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 133 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N020183-001AT1d4dbc9d85df4…
2026-11-14 07:37:172026-10N020183-002AT1d4dbc9d85df4…
2026-11-14 07:37:172026-10N020183-004AT1d4dbc9d85df4…
2026-10-15 13:18:302026-09N020183-001AT1c2088c7a36db…
2026-10-15 13:18:302026-09N020183-002AT1c2088c7a36db…
2026-10-15 13:18:302026-09N020183-004AT1c2088c7a36db…
2026-09-14 22:38:342026-08N020183-001AT184e616aacf4f…
2026-09-14 22:38:342026-08N020183-002AT184e616aacf4f…
2026-09-14 22:38:342026-08N020183-004AT184e616aacf4f…
2026-08-18 06:07:402026-07N020183-001AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N020183-002AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N020183-004AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020183-001AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020183-002AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020183-004AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020183-001AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020183-002AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020183-004AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08N020183-001AT16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020183-002AT16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020183-004AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020183-001AT1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020183-002AT1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020183-004AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020183-001AT1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020183-002AT1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020183-004AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020183-001AT103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020183-002AT103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020183-004AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020183-001AT12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020183-002AT12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020183-004AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020183-001AT15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020183-002AT15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020183-004AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020183-001AT1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020183-002AT1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020183-004AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020183-001AT1d06236e962d9…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
194f41a6-655b-456a-955f-7566eb429b7baa268d3f-7389-4f25-801f-5d4825495f082026-04-16Warnings, Adverse reactionsExact identifier
spl set id: aa268d3f-7389-4f25-801f-5d4825495f08

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.